Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Sepiapterin by PTC Therapeutics for Phenylketonuria (PKU): Likelihood of Approval
Sepiapterin is under clinical development by PTC Therapeutics and currently in Pre-Registration for Phenylketonuria (PKU). According to GlobalData, Pre-Registration drugs...
Risk adjusted net present value: What is the current valuation of PTC Therapeutics's Sepiapterin?
Sepiapterin is a small molecule commercialized by PTC Therapeutics, with a leading Pre-Registration program in Phenylketonuria (PKU). According to Globaldata,...
Risk adjusted net present value: What is the current valuation of PTC Therapeutics's Sepiapterin?
Sepiapterin is a small molecule commercialized by PTC Therapeutics, with a leading Phase III program in Phenylketonuria (PKU). According to...